There are 2789 resources available
445P - Tumor load surrogates as major prognostic factors in BRAF-V600E mutated (mt) colorectal (CRC) patients treated with BRAF inhibitor+antiEGFR +/- MEK inhibitor
Presenter: Francisco Javier Ros Montana
Session: ePoster Display
467P - Monocyte to red blood cells ratio (MRR): an innovative haematologic prognostic parameter in FOLFIRI-aflibercept treated patients: A subgroup analysis from the DISTINCTIVE trial
Presenter: Eleonora Lai
Session: ePoster Display
468P - Prognostic role of aspartate aminotransferase-to-alanine aminotransferase ratio and lactate dehydrogenase levels in resectable colorectal cancer
Presenter: Ma Yifei
Session: ePoster Display
469P - Potential emergent role of liquid biopsy in clinical practice in metastatic colorectal cancer (mCRC) treatment
Presenter: Valeria Zurlo
Session: ePoster Display
Resources:
Abstract
470P - Genomic landscape and its correlations with immunotherapy-related biomarkers in Chinese colorectal cancer patients
Presenter: Xiao Zheng
Session: ePoster Display
Resources:
Abstract
471P - Prognostic role of preoperative direct bilirubin-to-indirect bilirubin ratio and neutrophils-to-lymphocytes in resectable colorectal cancer
Presenter: Yifei Ma
Session: ePoster Display
472P - Characterizing the anal microbiome in proximal versus distal colorectal cancer
Presenter: Soham Ali
Session: ePoster Display
473P - A phase I study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in patients with advanced solid tumors including colorectal cancer (CRC)
Presenter: Akihito Kawazoe
Session: ePoster Display
474P - Genomic characterization and clinical outcomes of patients (pts) with metastatic colorectal cancer (mCRC) with peritoneal metastases (PM) in AACR project GENIE
Presenter: Enrique Sanz Garcia
Session: ePoster Display
455P - Concordance of baseline RAS mutational status (ms) between tissue and cell-free DNA (cfDNA) and association with overall response rate (ORR) in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study (cohort 2) (NCT02792478)
Presenter: Manuel Valladares-Ayerbes
Session: ePoster Display